Rahman Emamzadeh

Dr. Rahman Emamzadeh


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Enzyme and Microbial Technology
Verified
Journal Article
Closed access
SRSomaieh Rahnama
Somaieh Rahnama
BSBehnaz Saffar
Behnaz Saffar
ZKZahra Fanaei Kahrani
Zahra Fanaei Kahrani
MNMahboobeh Nazari
Mahboobeh Nazari
RERahman Emamzadeh
Rahman Emamzadeh

24 September 2012 in The Analyst
Verified
Journal Article
Closed access
PDF file
MNMahboobeh Nazari
Mahboobeh Nazari
RERahman Emamzadeh
Rahman Emamzadeh
SHSaman Hosseinkhani
Saman Hosseinkhani
LCLuca Cevenini
Luca Cevenini
Elisa MicheliniElisa Michelini
Elisa Michelini
ARAldo Roda
Aldo Roda
The Ca2+-dependent binding of Annexin V to phosphatidylserine on cell surfaces is a reliable marker for apoptosis that is widely used in flow cytometry based apoptosis assays. In this paper, we report a new class of Annexin V-based probes for apoptosis. Luciferase from Renilla reniformis (RLuc) was linked to Annexin V and expressed successfully in a soluble form in Escherichia coli BL21 (DE3). The new probe, Rluc/Annexin V, was purified and functionally assayed for detection of apoptosis in actinomycin D-induced apoptotic Jurkat cells. Moreover, the spontaneous apoptosis in neutrophils was shown using the new probe. The results indicate that Rluc/Annexin V can bind to the apoptotic cells, and the signal of Renilla luciferase can be detected by luminometric measurements. The availability of Rluc/Annexin V may be of potential commercial interest for improving current apoptosis assays.

1 May 2020 in Microbial Pathogenesis
Verified
Journal Article
Closed access
MAMohammad Reza Aliramaei
Mohammad Reza Aliramaei
MKMohamad Rabbani khorasgani
Mohamad Rabbani khorasgani
MRMohammad Reza Rahmani
Mohammad Reza Rahmani
SESayyed Hamid Zarkesh Esfahani
Sayyed Hamid Zarkesh Esfahani
RERahman Emamzadeh
Rahman Emamzadeh

21 April 2022 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MGMohadeseh Zarei Ghobadi
Mohadeseh Zarei Ghobadi
RERahman Emamzadeh
Rahman Emamzadeh
EAElaheh Afsaneh
Elaheh Afsaneh
Background: Adult T-cell Leukemia/Lymphoma (ATLL) is a cancer disease that is developed due to the infection by human T-cell leukemia virus type 1. It can be classified into four main subtypes including, acute, chronic, smoldering, and lymphoma. Despite the clinical manifestations, there are no reliable diagnostic biomarkers for the classification of these subtypes. Methods: Herein, we employed a machine learning approach, namely, Support Vector Machine-Recursive Feature Elimination with Cross-Validation (SVM-RFECV) to classify the different ATLL subtypes from Asymptomatic Carriers (ACs). The expression values of multiple mRNAs and miRNAs were used as the features. Afterward, the reliable miRNA-mRNA interactions for each subtype were identified through exploring the experimentally validated-target genes of miRNAs. Results: The results revealed that miR-21 and its interactions with DAAM1 and E2F2 in acute, SMAD7 in chronic, MYEF2 and PARP1 in smoldering subtypes could significantly classify the diverse subtypes. Conclusions: Considering the high accuracy of the constructed model, the identified mRNAs and miRNA are proposed as the potential therapeutic targets and the prognostic biomarkers for various ATLL subtypes.

3 November 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
MGMohadeseh Zarei Ghobadi
Mohadeseh Zarei Ghobadi
RERahman Emamzadeh
Rahman Emamzadeh
MTMajid Teymoori-Rad
Majid Teymoori-Rad
EAElaheh Afsaneh
Elaheh Afsaneh
Severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) is the causative virus of the pandemic coronavirus disease 2019 (COVID-19). Evaluating the immunological factors and other implicated processes underlying the progression of COVID-19 is essential for the recognition and then the design of efficacious therapies. Therefore, we analyzed RNAseq data obtained from PBMCs of the COVID-19 patients to explore coding and non-coding RNA diagnostic immunological panels. For this purpose, we integrated multiple RNAseq data and analyzed them overall as well as by considering the state of disease including severe and non-severe conditions. Afterward, we utilized a co-expressed-based machine learning procedure comprising weighted-gene co-expression analysis and differential expression gene as filter phase and recursive feature elimination-support vector machine as wrapper phase. This procedure led to the identification of two modules containing 5 and 84 genes which are mostly involved in cell dysregulation and innate immune suppression, respectively. Moreover, the role of vitamin D in regulating some classifiers was highlighted. Further analysis disclosed the role of discriminant miRNAs including miR-197-3p, miR-150-5p, miR-340-5p, miR-122-5p, miR-1307-3p, miR-34a-5p, miR-98-5p and their target genes comprising GAN, VWC2, TNFRSF6B, and CHST3 in the metabolic pathways. These classifiers differentiate the final fate of infection toward severe or non-severe COVID-19. The identified classifier genes and miRNAs may help in the proper design of therapeutic procedures considering their involvement in the immune and metabolic pathways.

25 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MGMohadeseh Zarei Ghobadi
Mohadeseh Zarei Ghobadi
RERahman Emamzadeh
Rahman Emamzadeh
SMSayed-Hamidreza Mozhgani
Sayed-Hamidreza Mozhgani
Adult T-cell leukemia/lymphoma (ATLL) is virus-caused cancer that originates from the infection by human T-cell leukemia virus type 1. ATLL dysregulates various biological pathways related to the viral infection and cancer progression through the dysexpression of miRNAs and mRNAs. In this study, the potential regulatory subnetworks were constructed aiming to shed light on the pathogenesis mechanism of ATLL. For this purpose, two mRNA and one miRNA expression datasets were firstly downloaded from the GEO database. Next, the differentially expressed genes and miRNAs (DEGs and DE-miRNAs, respectively), as well as differentially co-expressed gene pairs (DCGs), were determined. Afterward, common DEGs and DCGs targeted by experimentally validated DE-miRNAs were explored. The oncogenic and anti-oncogenic miRNA-mRNA regulatory subnetworks were then generated. The expression levels of four genes and two miRNAs were examined in the blood samples by qRT-PCR. The members of three oncogenic/anti-oncogenic subnetworks were generally enriched in immune, virus, and cancer-related pathways. Among them, FZD6, THBS4, SIRT1, CPNE3, miR-142-3p, and miR-451a were further validated by real-time PCR. The significant up-regulation of FZD6, THBS4, and miR-451a as well as down-regulation of CPNE3, SIRT1, and miR-142-3p were found in ATLL samples than normal samples. The identified oncogenic/anti-oncogenic subnetworks are pieces of the pathogenesis puzzle of ATLL. The ultimate winner is probably an oncogenic network that determines the final fate of the disease. The identified genes and miRNAs are proposed as novel prognostic biomarkers for ATLL.